In a filing, Edwards Lifesciences Corp revealed its CVP, JAPAC Lippis Daniel J. unloaded Company’s shares for reported $34382.0 on Jan 16 ’25. In the deal valued at $68.76 per share,500 shares were sold. As a result of this transaction, Lippis Daniel J. now holds 23,189 shares worth roughly $1.68 million.
Then, BOBO DONALD E JR sold 5,000 shares, generating $343,736 in total proceeds. Upon selling the shares at $68.75, the CVP,Strategy/Corp Development now owns 46,936 shares.
Before that, Lippis Daniel J. bought 500 shares. Edwards Lifesciences Corp shares valued at $34,382 were divested by the Officer at a price of $68.76 per share.
Stifel upgraded its Edwards Lifesciences Corp [EW] rating to a Buy from a a Hold in a research note published on January 30, 2025; the price target was increased to $90 from $75. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who decreased its forecast for the stock in mid January from “a Peer perform” to “an Underperform”. BofA Securities also remained covering EW and has increased its forecast on December 16, 2024 with a “Buy” recommendation from previously “Neutral” rating.
Price Performance Review of EW
On Friday, Edwards Lifesciences Corp [NYSE:EW] saw its stock fall -1.05% to $72.45. Over the last five days, the stock has gained 5.02%. Edwards Lifesciences Corp shares have fallen nearly -2.13% since the year began. Nevertheless, the stocks have fallen -1.96% over the past one year. While a 52-week high of $96.12 was reached on 01/08/25, a 52-week low of $58.93 was recorded on 01/22/25. SMA at 50 days reached $72.19, while 200 days put it at $75.62.
Levels Of Support And Resistance For EW Stock
The 24-hour chart illustrates a support level at 72.07, which if violated will result in even more drops to 71.69. On the upside, there is a resistance level at 73.15. A further resistance level may holdings at 73.85. The Relative Strength Index (RSI) on the 14-day chart is 53.55, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.73, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 25.31%. Stochastics %K at 68.08% indicates the stock is a holding.
How much short interest is there in Edwards Lifesciences Corp?
A steep rise in short interest was recorded in Edwards Lifesciences Corp stocks on 2025-01-15, growing by 1.74 million shares to a total of 9.04 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 7.3 million shares. There was a rise of 19.28%, which implies that there is a positive sentiment for the stock.
